All of the following are recognized indications for thyroid surgery in benign thyroid disease EXCEPT:

## Indications for Thyroid Surgery in Benign Disease **Key Point:** Surgery in benign thyroid disease is indicated for functional or mechanical complications, or significant cosmetic deformity — but NOT for asymptomatic subclinical hyperthyroidism in a young, low-risk patient without cardiac disease, osteoporosis, or atrial fibrillation. ### Accepted Surgical Indications | Indication | Rationale | |---|---| | **Graves' disease with refractory ophthalmopathy** | Thyroidectomy reduces thyroid antigen (TSH-R) load; indicated when refractory to medical/RAI therapy (Option A ✓) | | **Compressive symptoms** | Dysphagia, dyspnea, stridor from mass effect are classic indications for surgery (Option B ✓) | | **Cosmetic concern** | A large, visible goiter or nodule causing cosmetic disfigurement is a recognized (relative) indication per ATA 2015 guidelines, even with benign cytology in a euthyroid patient (Option C ✓) | | **Subclinical hyperthyroidism in young, asymptomatic patient** | NOT a standard surgical indication; observation or antithyroid drugs preferred (Option D ✗ — the EXCEPT answer) | ### Why Option D is the EXCEPT Answer Multinodular goiter with **subclinical hyperthyroidism** (suppressed TSH, normal free T4/T3) in an **asymptomatic 35-year-old** without cardiac disease, atrial fibrillation, or osteoporosis does NOT constitute a recognized indication for thyroid surgery. Per the Endocrine Society and ATA guidelines, surgery (or definitive therapy) for subclinical hyperthyroidism is reserved for: - Patients **>65 years** of age - Those with **cardiac disease** (atrial fibrillation, heart failure) - Those with **osteoporosis** or significant bone loss - **Symptomatic** patients In a young, asymptomatic, low-risk patient, conservative management (observation, antithyroid drugs) is the preferred approach. Surgery is not first-line for subclinical disease in this demographic. ### Why the Other Options ARE Recognized Indications - **Option A:** Graves' disease with severe ophthalmopathy refractory to medical and radioiodine therapy is a well-established indication for thyroidectomy, endorsed by ATA/ETA guidelines, as total thyroidectomy reduces TSH-receptor antigen stimulation and may stabilize or improve ophthalmopathy. - **Option B:** Compressive symptoms (dysphagia, dyspnea) from a thyroid nodule or goiter are a classic, well-established indication for thyroidectomy regardless of cytology. - **Option C:** Cosmetic concern for a large, visible thyroid nodule or goiter is a **recognized relative indication** for surgery per ATA 2015 Thyroid Nodule Guidelines, even in euthyroid patients with benign cytology, when the cosmetic deformity is significant and the patient desires intervention. **High-Yield:** The classic NEET PG trap here is confusing cosmetic concern (a recognized relative indication) with asymptomatic subclinical hyperthyroidism in a young patient (NOT an indication). Age and risk stratification are critical — surgery for subclinical hyperthyroidism is reserved for older patients or those with comorbidities. **Clinical Pearl:** Do not confuse "subclinical hyperthyroidism" with overt hyperthyroidism. In young, asymptomatic patients without risk factors (no cardiac disease, no osteoporosis, age <65), surgery is not first-line for subclinical disease. [cite: ATA Management Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer, 2015; Endocrine Society Clinical Practice Guideline on Hyperthyroidism, 2016]